BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36725697)

  • 21. Follow-up after primary treatment of soft tissue sarcoma of extremities: impact of frequency of follow-up imaging on disease-specific survival.
    Chou YS; Liu CY; Chen WM; Chen TH; Chen PC; Wu HT; Chiou HJ; Shiau CY; Wu YC; Liu CL; Chao TC; Tzeng CH; Yen CC
    J Surg Oncol; 2012 Aug; 106(2):155-61. PubMed ID: 22297812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall.
    Rutkowski P; Trepka S; Ptaszynski K; Kołodziejczyk M
    Clin Orthop Relat Res; 2013 Mar; 471(3):860-70. PubMed ID: 22972658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
    Okuno S; Petersen I; Shives T; Mahoney M; Haddock M; Sim F; O'Connor MI; Markovic SN; Maples W
    Am J Clin Oncol; 2016 Apr; 39(2):204-9. PubMed ID: 24487418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis.
    Chouliaras K; Patel N; Senehi R; Ethun CG; Poultsides G; Grignol V; Gamblin TC; Roggin KK; Fields RC; D'Agostino R; Levine EA; Cardona K; Votanopoulos K
    J Surg Oncol; 2021 Feb; 123(2):479-488. PubMed ID: 33150594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Vacuum-assisted Closure Reduce the Risk of Wound Complications in Patients With Lower Extremity Sarcomas Treated With Preoperative Radiation?
    Bedi M; King DM; DeVries J; Hackbarth DA; Neilson JC
    Clin Orthop Relat Res; 2019 Apr; 477(4):768-774. PubMed ID: 30811365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept].
    Schwarzbach M; Lehnert T; Willeke F; Hinz U; Herfarth C
    Chirurg; 1996 Dec; 67(12):1237-43. PubMed ID: 9081786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term Outcome of 181 Patients With Liposarcomas of the Extremity and Truncal Wall.
    Goertz O; Pieper A; Lauer H; Stricker I; Dadras M; Behr B; Lehnhardt M; Harati K
    Anticancer Res; 2019 Oct; 39(10):5747-5753. PubMed ID: 31570477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis.
    Gingrich AA; Bateni SB; Monjazeb AM; Darrow MA; Thorpe SW; Kirane AR; Bold RJ; Canter RJ
    Ann Surg Oncol; 2017 Oct; 24(11):3252-3263. PubMed ID: 28741123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities.
    Aguiar Junior S; Ferreira Fde O; Rossi BM; Santos EM; Salvajoli JV; Lopes A
    Clinics (Sao Paulo); 2009; 64(11):1059-64. PubMed ID: 19936179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
    Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
    J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity.
    Chowdhary M; Sen N; Jeans EB; Miller L; Batus M; Gitelis S; Wang D; Abrams RA
    Am J Clin Oncol; 2019 Jan; 42(1):1-5. PubMed ID: 29782358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of soft tissue sarcomas (STS) in first isolated local recurrence: a retrospective study of 83 cases.
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Radiother Oncol; 2004 Dec; 73(3):313-9. PubMed ID: 15588876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity.
    Sabolch A; Feng M; Griffith K; Rzasa C; Gadzala L; Feng F; Biermann JS; Chugh R; Ray M; Ben-Josef E
    Am J Clin Oncol; 2012 Apr; 35(2):151-7. PubMed ID: 21336091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Resection Margin Classifications for High-grade Pleomorphic Soft Tissue Sarcomas of the Extremity or Trunk After Neoadjuvant Cytotoxic Therapy.
    Cates VM; Cates JMM
    Am J Surg Pathol; 2019 Jun; 43(6):844-850. PubMed ID: 30932925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.
    Nesseler JP; Salleron J; Rios M; Nickers P; Marchal F; Brocard F; Peiffert D; Vogin G
    Radiother Oncol; 2017 Oct; 125(1):160-167. PubMed ID: 28951009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].
    Lehnhardt M; Hirche C; Daigeler A; Goertz O; Ring A; Hirsch T; Drücke D; Hauser J; Steinau HU
    Chirurg; 2012 Feb; 83(2):143-52. PubMed ID: 21695557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysis.
    Gouin F; Stoeckle E; Honoré C; Ropars M; Jafari M; Mattei JC; Rochwerger A; Carrere S; Waast D; Ferron G; Machiavello JC; Anract P; Marchal F; Sirveaux F; Marco O; Guiramand J; Paquette B; Di Marco A; Causeret S; Guilloit JM; Soibinet P; Tzanis D; Gimbergues P; Fiorenza F; Dujardin F; Le Nail LR; Ruzic JC; Chemin-Airiau C; Morelle M; Meeus P; Karanian M; Le Loarer F; Vaz G; Blay JY;
    BMC Cancer; 2022 Oct; 22(1):1034. PubMed ID: 36192725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.